Showing results (2271-2280 of 4,223) with videos related to
Sort By:
Pageof 423
Discover Oncology|October 17, 2024
Circ_0001047 inhibits prostate cancer progression and enhances abiraterone sensitivity via miR-122-5p/FKBP5/PHLPP1/AKT axis in vitroZhenjie Chen, Shi Fu, Yiqian Shan, et al.Discover Oncology|October 15, 2024
Development trends and knowledge framework of artificial intelligence (AI) applications in oncology by years: a bibliometric analysis from 1992 to 2022Murat Koçak, Zafer AkçalıDiscover Oncology|October 15, 2024
MicroRNA-34a negatively regulates Netrin1 and mediates MEK/ERK pathway to regulate chemosensitivity of gastric cancer cellsHaiping Liu, Limin WangDiscover Oncology|October 15, 2024
Expression of CLDN1 and EGFR in PTCJunJie Wu, YouMei Wang, Lei Yan, et al.Discover Oncology|October 14, 2024
AURKA inhibition shows promise as a therapeutic strategy for ARID1A-mutant colorectal cancerRong-Sheng Qin, Chun-Tao Li, Fei Chen, et al.Discover Oncology|October 10, 2024
Application of artificial intelligence model in pathological staging and prognosis of clear cell renal cell carcinomaJing Yao, Lai Wei, Peipei Hao, et al.Discover Oncology|October 10, 2024
Selection determines therapeutic effects: a retrospective analysis of the application of different frailty tools in elderly patients with multiple myelomaYujun Li, Songying Zhao, Jianmei Xu, et al.Discover Oncology|October 10, 2024
Prognostic risk model of LIHC T-cells based on scRNA-seq and RNA-seq and the regulation of the tumor immune microenvironmentShoupeng Ding, Xiaomei Yi, Jinghua Gao, et al.Discover Oncology|October 4, 2024
Radiosensitivity in individuals with tuberous sclerosis complexLukas Kuhlmann, Jenny Stritzelberger, Rainer Fietkau, et al.Discover Oncology|October 4, 2024
Identification of KLHL17 as a prognostic marker for prostate cancer based on single-cell sequencing and in vitro/in vivo experimentsQingyu Zhou, Dan Guo, Tong Shen, et al.Pageof 423